Vedbæk, Denmark

Marianne Dragheim

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Vedbaek, DK (2016)
  • Vedbæk, DK (2017 - 2023)

Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marianne Dragheim

Introduction

Marianne Dragheim is a notable inventor based in Vedbæk, Denmark. She has made significant contributions to the field of pharmaceuticals, holding a total of three patents. Her work focuses on therapeutic uses of compounds that exhibit combined activity on various serotonin receptors.

Latest Patents

Among her latest patents is a groundbreaking invention related to the therapeutic uses of compounds having combined sert, 5-HT3, and 5-HT1a activity. Additionally, she has developed new pharmaceutical uses for 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and its pharmaceutically acceptable salts. These innovations are poised to enhance treatment options in the pharmaceutical industry.

Career Highlights

Throughout her career, Marianne has worked with prominent companies such as H. Lundbeck A/S and Takeda Pharmaceuticals North America, Inc. Her experience in these organizations has allowed her to refine her expertise and contribute to significant advancements in drug development.

Collaborations

Marianne has collaborated with esteemed colleagues, including Nicholas Moore and Ioana Florea. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Marianne Dragheim's contributions to the pharmaceutical field through her patents and collaborations highlight her role as a key innovator. Her work continues to influence the development of new therapeutic options, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…